- Home
- TNXP vs OM Comparison
TNXP vs OM Comparison
Compare TNXP & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- OM
- Stock Information
- Founded
- TNXP 2007
- OM 2003
- Country
- TNXP United States
- OM United States
- Employees
- TNXP N/A
- OM N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TNXP Health Care
- OM Health Care
- Exchange
- TNXP Nasdaq
- OM Nasdaq
- Market Cap
- TNXP 272.0M
- OM 305.5M
- IPO Year
- TNXP N/A
- OM 2020
- Fundamental
- Price
- TNXP $49.73
- OM $18.53
- Analyst Decision
- TNXP Strong Buy
- OM Buy
- Analyst Count
- TNXP 2
- OM 2
- Target Price
- TNXP $585.00
- OM $33.00
- AVG Volume (30 Days)
- TNXP 1.2M
- OM 411.2K
- Earning Date
- TNXP 08-15-2025
- OM 08-06-2025
- Dividend Yield
- TNXP N/A
- OM N/A
- EPS Growth
- TNXP N/A
- OM N/A
- EPS
- TNXP N/A
- OM N/A
- Revenue
- TNXP $10,041,000.00
- OM $115,273,000.00
- Revenue This Year
- TNXP $22.87
- OM $10.80
- Revenue Next Year
- TNXP $711.66
- OM $11.99
- P/E Ratio
- TNXP N/A
- OM N/A
- Revenue Growth
- TNXP N/A
- OM N/A
- 52 Week Low
- TNXP $6.76
- OM $5.85
- 52 Week High
- TNXP $130.00
- OM $59.33
- Technical
- Relative Strength Index (RSI)
- TNXP 70.46
- OM 48.27
- Support Level
- TNXP $41.64
- OM $17.16
- Resistance Level
- TNXP $46.00
- OM $19.60
- Average True Range (ATR)
- TNXP 3.70
- OM 1.17
- MACD
- TNXP 0.38
- OM -0.16
- Stochastic Oscillator
- TNXP 95.84
- OM 35.06
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.